देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
Laronidase
Genzyme Australasia Pty Ltd
Medicine Registered
VERSION: ALD ANZ CMI A1202-01 SUPERCEDES: ALD ANZ CMI A0901-01 COMMERCIAL Page 1 of 3 ALDURAZYME _ _ _[al-dur-a-ZIME]_ laronidase-rch _[lar-on-I-daze R.C.H.] _500 U, Concentrate for Solution for Infusion CONSUMER MEDICINE INFORMATION_ _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ALDURAZYME. It does not contain all the available information. It does not take the place of talking to your treating physician or a trained health care professional. All medicines have risks and benefits. Your treating physician has weighed the risks of you or your child having ALDURAZYME against the benefits they expect it will have. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR TREATING PHYSICIAN OR NURSE. KEEP THIS LEAFLET. You may need to read it again. WHAT ALDURAZYME IS USED FOR ALDURAZYME is used as enzyme replacement therapy in Mucopolysaccharidosis I (MPS I) storage disorder, a disease in which the level of -L-iduronidase is absent or lower than normal. _ _ _HOW IT WORKS _ Patients with MPS I disease do not produce enough of their own enzyme, -L-iduronidase. The reduced or absent -L-iduronidase activity in patients results in the accumulation of substances called glycosaminoglycans (GAGs) in most cell types and tissues. ALDURAZYME is an enzyme replacement therapy that is intended to restore a level of enzyme activity sufficient to remove the accumulated GAGs and to prevent further accumulation. BEFORE YOU ARE GIVEN ALDURAZYME _WHEN YOU OR YOUR CHILD _ _MUST NOT BE GIVEN IT _ DO NOT TAKE ALDURAZYME IF YOU OR YOUR CHILD HAVE A KNOWN, SEVERE, LIFE-THREATENING ALLERGIC REACTION TO ANY OF THE INGREDIENTS LISTED AT THE END OF THIS LEAFLET. Symptoms of an allergic reaction may inclu पूरा दस्तावेज़ पढ़ें